New treatment option for Rectus Diastasis
Official title Abdominal Rectus Diastasis (ARD) Reconstruction
ClinicalTrials.gov ID: NCT04182412
What this study is testing
- What it's testing
- The aim of this study is to investigate whether abdominal wall reconstruction through laparoscopic surgery can be recommended as a safe treatment alternative for patients with symptomatic rectus diastasis, and if this type of treatment leads to improved quality of life, trunk stability and reduced pain.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Rectus diastasis ≥3 cm
- BMI =\<28 kg/m2
- non smoker
- abdominal instability,
- abdominal wall and/or lower back pain despite physical therapy / structured physical exercise for at least 6 months
You likely can't join if
- BMI \>28 kg/m2
- Smoking
- Ongoing immunosuppressive therapy
- Current pregnancy ≥16 weeks gestational age for the last 12 months
- Pregnant or women who wish to become pregnant
- Previously extensive abdominal wall surgery incl hernia surgery (NOT including sectio, appendectomy, small umbilical herniae)
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Region Stockholm, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Region Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.